Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial-Reference-Cited by-同舟云学术

Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial

Published:2022-04 Issue:4 Volume:9 Page:291-306
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Schmidt-Kraepelin Christian,Feyerabend Sandra,Engelke Christina,Riesbeck Mathias,Meisenzahl-Lechner Eva,Verde Pablo-Emilio,Correll Christoph U,Kluge Michael,Makiol Christian,Neff Andrea,Lange Christina,Englisch Susanne,Zink Mathias,Langguth Berthold,Poeppl Timm B,Reske Dirk,Gouzoulis-Mayfrank Euphrosyne,Gründer Gerhard,Hasan Alkomiet,Brockhaus-Dumke Anke,Jäger Markus,Baumgärtner Jessica,Leucht Stefan,Cordes Joachim,Schmidt-Kraepelin Christian,Cordes Joachim,Feyerabend Sandra,Engelke Christina,Riesbeck Mathias,Meisenzahl-Lechner Eva,Gaebel Wolfgang,Deiß Martina,Sofie Natalia,Galuba Viktoria,Wiechmann Frank,Janssen Birgit,Kluge Michael,Makiol Christian,Kertzscher Lisa,Neff Andrea,Lange Christina,Englisch Susanne,Zink Mathias,Becker Anna,Muszinski Sandra,Gründer Gerhard,Langguth Berthold,Poeppl Timm,Frank Elmar,Kreuzer Peter,Reske Dirk,Gouzoulis-Mayfrank Euphrosyne,Veselinovic Tanja,Hasan Alkomiet,Falkai Peter,Wagner Elias,Brockhaus-Dumke Anke,Klos Bettina,Jäger Markus,Lang Fabian,Kling-Lourenço Paulo,Baumgärtner Jessica,Hasan Alkomiet,Dreimüller Nadine,Hiemke Christoph,Leucht Stefan,Heres Stephan,Leucht Claudia,Assion Hans-Jörg,Kis Bernhard,Zilles-Wegner David,Kahl Kai,Correll Christoph,Verde Pablo-Emilio,Kolbe Henrike,Rottmann Anika

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference30 articles.

1. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009;Gallego;Schizophr Res,2012

2. Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors;Leucht;Am J Psychiatry,2017

3. Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: a systematic review and meta-analysis;Matsui;Schizophr Res,2019

4. Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis;Galling;World Psychiatry,2017

5. Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29823 patients with schizophrenia;Tiihonen;JAMA Psychiatry,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data;Schizophrenia Research;2024-10

2. The eGFR parameter model helps predict blood drug concentration of amisulpride in patients with schizophrenia;2024-08-09

3. Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-study;Schizophrenia Research;2024-08

4. Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline;Neuropsychiatric Disease and Treatment;2024-06

5. A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications;Frontiers in Pharmacology;2023-05-02